Oppenheimer & Co. Inc. lessened its position in Dollar Tree, Inc. (NASDAQ:DLTR – Get Rating) by 24.9% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 3,168 shares of the company’s stock after selling 1,050 shares during the period. Oppenheimer & Co. Inc.’s holdings in Dollar Tree were worth $432,000 at the end of the most recent reporting period.
A number of other large investors have also added to or reduced their stakes in the company. SVB Wealth LLC grew its holdings in Dollar Tree by 2.4% in the 2nd quarter. SVB Wealth LLC now owns 2,657 shares of the company’s stock worth $414,000 after acquiring an additional 62 shares during the last quarter. Trust Asset Management LLC grew its holdings in Dollar Tree by 2.8% in the 2nd quarter. Trust Asset Management LLC now owns 2,358 shares of the company’s stock worth $367,000 after acquiring an additional 64 shares during the last quarter. Keybank National Association OH boosted its stake in shares of Dollar Tree by 3.3% during the 2nd quarter. Keybank National Association OH now owns 2,469 shares of the company’s stock valued at $385,000 after purchasing an additional 79 shares in the last quarter. NuWave Investment Management LLC boosted its stake in shares of Dollar Tree by 9.3% during the 3rd quarter. NuWave Investment Management LLC now owns 933 shares of the company’s stock valued at $127,000 after purchasing an additional 79 shares in the last quarter. Finally, Ballentine Partners LLC boosted its stake in shares of Dollar Tree by 5.9% during the 3rd quarter. Ballentine Partners LLC now owns 1,486 shares of the company’s stock valued at $202,000 after purchasing an additional 83 shares in the last quarter. Institutional investors own 97.04% of the company’s stock.
Dollar Tree Stock Up 1.9 %
Shares of Dollar Tree stock opened at $144.00 on Friday. The company has a debt-to-equity ratio of 0.41, a quick ratio of 0.17 and a current ratio of 1.38. The stock has a market capitalization of $32.25 billion, a PE ratio of 20.06, a price-to-earnings-growth ratio of 1.24 and a beta of 0.70. Dollar Tree, Inc. has a 52-week low of $124.76 and a 52-week high of $177.19. The company has a 50-day simple moving average of $146.04 and a two-hundred day simple moving average of $148.16.
Wall Street Analysts Forecast Growth
A number of equities research analysts have recently weighed in on DLTR shares. Telsey Advisory Group cut their target price on shares of Dollar Tree from $170.00 to $165.00 and set an “outperform” rating on the stock in a research note on Friday. Credit Suisse Group started coverage on shares of Dollar Tree in a research note on Monday, December 19th. They set a “neutral” rating and a $150.00 target price on the stock. OTR Global raised shares of Dollar Tree from a “mixed” rating to a “positive” rating in a research note on Wednesday, November 16th. Barclays began coverage on shares of Dollar Tree in a research note on Tuesday, February 7th. They set an “equal weight” rating and a $145.00 target price on the stock. Finally, TheStreet raised shares of Dollar Tree from a “c+” rating to a “b-” rating in a research note on Monday, October 31st. Four equities research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $170.50.
About Dollar Tree
Dollar Tree, Inc owns and operates discount variety stores offering merchandise at fixed prices. It operates through the Dollar Tree and Family Dollar segments. The Dollar Tree segment includes operations under Dollar Tree and Dollar Tree Canada brands, with its distribution centers in the United States and Canada.
Featured Articles
- Get a free copy of the StockNews.com research report on Dollar Tree (DLTR)
- Carvana Skidding On Revenue Decrease, Heavy Debt Burden
- What Are Consumer Staples Stocks?
- Is Rocky Brands Dividend A Good Fit For Your Portfolio?
- Beyond Meat Stock Is Not Beyond Hope
- Analysts Holding As Pfizer Waits On Two Phase 3 Studies
Receive News & Ratings for Dollar Tree Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dollar Tree and related companies with MarketBeat.com's FREE daily email newsletter.